Диссертация (Свободные и координированные ионами Pt(II), Pd(II) тетразолилуксусные кислоты как перспективные скаффолды в синтезе новых биологически активных веществ), страница 19
Описание файла
Файл "Диссертация" внутри архива находится в папке "Свободные и координированные ионами Pt(II), Pd(II) тетразолилуксусные кислоты как перспективные скаффолды в синтезе новых биологически активных веществ". PDF-файл из архива "Свободные и координированные ионами Pt(II), Pd(II) тетразолилуксусные кислоты как перспективные скаффолды в синтезе новых биологически активных веществ", который расположен в категории "". Всё это находится в предмете "химия" из Аспирантура и докторантура, которые можно найти в файловом архиве СПбГУ. Не смотря на прямую связь этого архива с СПбГУ, его также можно найти и в других разделах. , а ещё этот архив представляет собой кандидатскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени кандидата химических наук.
Просмотр PDF-файла онлайн
Текст 19 страницы из PDF
Synthesis and evaluation of 1, 5-disubstituted tetrazoles as rigidanalogues of combretastatin A-4 with potent antiproliferative and antitumoractivity. J. Med. Chem., 2012, 55, 475−488.51.Jedhe, G.S.; Paul, D.; Gonnade, R.G.; Santra, M.K.; Hamel, E.; Nguyen, T.L.;Sanjayan, G.J. Correlation of hydrogen-bonding propensity and anticancerprofile of tetrazole-tethered combretastatin analogues. Bioorg. Med. Chem. Lett.,2013, 23(16), 4680–4684.52. Beale, T.M.; Allwood, D.M.; Bender, A.; Bond, P.J.; Brenton, J.D.; CharnockJones, D.S.; Ley, S.V.; Myers, R.M.; Shearman, J.W.; Temple, J.; Unger, J.;Watts, C.A.; Xian, J.
A-Ring dihalogenation increases the cellular activity ofcombretastatin-templated tetrazoles. ACS Med. Chem. Lett., 2012, 3, 177−181.14653. Lu, Y.; Chen, J.; Xiao, M.; Li, W.; Miller, D.D. An Overview of TubulinInhibitors That Interact with the Colchicine Binding. Site Pharm. Res., 2012,29(11), 2943–2971.54. Marsham, P.R.; Wardleworth, G.M.; Boyle, F.T.; Hennequin, L.F., Kimbell,К.; Brown, M.; Jackman. A.L. Design and synthesis of potent nonpolyglutamatable quinazoline antifolate thymidylate synthase inhibitors. J.
Med.Chem., 1999, 42, 3809-3820.55. Bavetsias, V.; Marriott, J.H.; Melin, C.; Kimbell, R.; Matusiak, Z.S.; Boyle,F.T.; Jackman, A.L. Design and synthesis of cyclopenta[g]quinazoline-basedantifolates as inhibitors of thymidylate synthase and potential antitumor agents.Synthesis and biological properties of amino acids and peptides containing atetrazolyl moiety. J. Med. Chem., 2000, 43, 1910-1926.56.Wang, B.; Huang, P.-H.; Chen, C.-S.; C.J. Forsyth. Total syntheses of thehistone deacetylase inhibitors largazole and 2-epi-largazole: application of Nheterocyclic carbene mediated acylations in complex molecule synthesis.
J OrgChem., 2011, 76(4), 1140–1150.57.Li, X.; Tu, Z.; Li, H.; Liu, C.; Li, Z.; Sun, Q.; Yao, Y.; Liu, J.; Jiang, S.Biological Evaluation of New Largazole Analogues: Alteration of MacrocyclicScaffold with Click Chemistry. ACS Med. Chem. Lett., 2013, 4(1), 132–136.58. Lamberts, S.W.J.; Van Der Lely, A.-J.; De Herder, W.W. Octreotide. N. Eng. J.Med., 1996, 334, 246–254.59. Barbieri, F.; Bajetto, A.; Pattarozzi, A.; Gatti, M.; Würth, R.; Thellung, S.;Corsaro, A.; Villa, V.; Nizzari, M.; Florio, T. Peptide receptor targeting incancer: the somatostatin paradigm.
Int. J. Pept., 2013, 1–21.60. Popova, E.A.; Nikolskaia, S.K.; Gluzdikov, I.A.; Trifonov, R.E. An efficientsynthesis of a novel analog of octreotide with an unnatural L-lysine-liketetrazolyl amino acid. Tetrahedron Lett., 2014, 55, 5041-5046.61.Chuprun, S.S.; Popova, E.A.; Mukhametshina, A.V.; Trifonov, R.E. Synthesisof tetrazol-1-yl analogs of L-lysine and L-ornithine. Russ. J.
Org. Chem.,2015, 51(11), 1671–1673.14762. Baranovskii, A.V.; Litvinovskaya, R.P.; Khripach, V.A. Steroids with a sidechain containing a heterocyclic fragment: synthesis and transformations. Russ.Chem. Rev., 1993, 62(7) 661–682.63. Stulov, S.V.; Misharin, A.Yu. Synthesis of steroids with nitrogen-containingsubstituents in ring D (Review).
Chem. Heterocycl. Comp., 2013, 48(10),1431–1472.64. Shamsuzzaman A.M.; Ali, A.; Mashrai, А.; Khanam, H.; Sherwani, A.; Owais,M Design, synthesis and biological evaluation of steroidal tetrazoles asantiproliferative and antioxidant agents. Eur. Chem. Bull., 2014, 3(11), 1075–1080.65. Penov-Gaši, K.M.; Oklješa, A.M.; Petri, E.T.; Ćelić, A.S.; Djurendić, E.A.;Klisurić, O.R.; Csanadi, J.J.; Batta, G.; Nikolić, A.R.; Jakimov, D.S.; Sakać,M.N. Selective antitumour activity and ERα molecular docking studies of newlysynthesized D-homo fused steroidal tetrazoles.
Med. Chem. Commun., 2013, 4,317–323.66. Gundugola, A.S.; Chandra, K.L.; Perchellet, E.M.; Waters, A.M.; Perchellet, J.P.H.; Rayat, S. Synthesis and antiproliferative evaluation of 5-oxo and 5-thioderivatives of 1,4-diaryl tetrazoles. Bioorg. Med. Chem. Lett., 2010, 20, 3920–3924.67. Kaplancıklı, Z.A.; Yurttas, L.; Őzdemir, A.; Turan-Zitouni, G.; Çiftci, G.A.;Yıldırım, S.U.; Mohsen, U.A. Synthesis and antiproliferative activity of new1,5-disubstituted tetrazoles bearing hydrazone moiety.
Med. Chem. Res.,2014, 23, 1067–1075.68. Ozkay, Y.; Incesu, Z.; Őnder, N.I.; Tunalı T.; Karaca, H.; Ișikdağ, I.; Uçucu, Ü.Antimicrobial and anticancer effects of some 2-(substitutedsulfanyl)-N-(5methyl-isoxazol-3-yl)acetamide derivatives. Med. Chem. Res., 2013, 22,211–218.69. Zhang, S.-Y.; Fu, D.-J.; Yue, X.-X.; Liu, Y.-C.; Song, J.; Sun, H.-H., Liu, H.M.; Zhang. Design, Y.-B. Synthesis and structure-activity relationships of novel148chalcone-1,2,3-triazole-azole derivates as antiproliferative agents. Molecules,2016, 21(653), 1–13.70.
Malani, M.H.; Dholakiya, Z.; Ibrahim, A.S.; Badria, F.A. Synthesis andselective cytotoxicity of novel biphenyl-based tetrazole derivatives. Med. Chem.Res., 2014, 23(10), 4427–4435.71. Ozen, F.; Tekin, S.; Koran, K.; Sandal, S.; Görgülü, A.O.
Synthesis, structuralcharacterization, and in vitro anti-cancer activities of new phenylacrylonitrilederivatives. Appl. Biol. Chem., 2016, 59(2), 239–248.72. Maddila, S.; Naicker, K.; Momin, M.I.K.; Rana, S.; Gorle, S.; Maddila, S.;Yalagala, K.; Singh, M.; Koorbanally, N.A.; Jonnalagadda, S.B.
Novel 2-(1(substitutedbenzyl)-1H-tetrazol-5-yl)-3-phenylacrylonitrilederivatives:synthesis, in vitro antitumor activity and computational studies. Med. Chem.Res., 2016, 25(2), 283–291.73. Kumar, C.N.S.S.P.; Parida, D.K.; Santhoshi, A.; Kota, A.K.; Sridhar, B.; Rao,V.J.
Synthesis and biological evaluation of tetrazole containing compounds aspossible anticancer agents. Med. Chem. Comm., 2011, 2, 486-492.74. Rostom, S.A., Ashour, H. M., El Razik, H.A.; El Fattah, H.; El Fattah, Ael.F.;El-Dinl, N.N. Azole antimicrobial pharmacophore-based tetrazoles: Synthesisand biological evaluation as potential antimicrobial and anticonvulsant agents.Bioorg.Med.Chem., 2009, 17, 2410–2422.75.
Bhaskar, V. H.; Mohite, P.B. Synthesis, characterization and evaluation ofanticancer activity of some tetrazole derivatives. Journal of Optoelectronicsand Biomedical Materials, 2010, 2(4), 249–259.76. Krištafor, S.; Bistrovic, A.; Plavec, J.; Makuc, D.; Martinovic, T.; KraljevicPavelice, S.; Raic-Malic, S. One-pot click synthesis of 1,2,3-triazole-embeddedunsaturated uracil derivatives and hybrids of 1,5- and 2,5-disubstituted tetrazolesand pyrimidines. Tetrahedron Lett., 2015, 56(10), 1222–1228.77.
Hussein, A.; Ahmed, O. Regioselective one-pot synthesis and anti-proliferativeand apoptotic effects of some novel tetrazolo [1, 5-a] pyrimidine derivatives.Bioorg. Med. Chem., 2010, 18, 2639–2644.14978. Arshad, M.; Bhat, A.R.; Pokharel, S.; Kim, J.; Lee, J.; Athar, F.; Choi, I.Synthesis, сharacterization and anticancer screening of some novel piperonyltetrazole derivatives. Eur. J. Med. Chem., 2014, 71, 229–236.79.
El-Sayed, W.A.; El-Kosy, S.M.; Ali, O.M.; Emselm, H.M.; Abdel-Rahman, A.Anticancer activity of new (tetrazol-5-yl)methylindile derivatives and theiracyclic C-nucleoside analogs. Acta Pol. Pharm., 2012, 69(4), 669-677.80.Zhang, S.-Y.; Fu, D.-J.; Yue, X.-X.; Liu, Y.-C.; Song, J.; Sun, H.-H., Liu, H.M.; Zhang. Design, Y.-B.
Synthesis and structure-activity relationships of novelchalcone-1,2,3-triazole-azole derivates as antiproliferative agents. Molecules,2016, 21(653), 1–13.81. Malani, M.H.; Dholakiya, Z.; Ibrahim, A.S.; Badria, F.A. Synthesis andselective cytotoxicity of novel biphenyl-based tetrazole derivatives.
Med. Chem.Res., 2014, 23(10), 4427–4435.82. Ozen, F.; Tekin, S.; Koran, K.; Sandal, S.; Görgülü, A.O. Synthesis, structuralcharacterization, and in vitro anti-cancer activities of new phenylacrylonitrilederivatives. Appl. Biol. Chem., 2016, 59(2), 239–248.83. Maddila, S.; Naicker, K.; Momin, M.I.K.; Rana, S.; Gorle, S.; Maddila, S.;Yalagala, K.; Singh, M.; Koorbanally, N.A.; Jonnalagadda, S.B. Novel 2-(1(substitutedbenzyl)-1H-tetrazol-5-yl)-3-phenylacrylonitrilederivatives:synthesis, in vitro antitumor activity and computational studies. Med. Chem.Res., 2016, 25(2), 283–291.84.Beale, T.M.; Allwood, D.M.; Bender, A.; Bond, P.J.; Brenton, J.D.; CharnockJones, D.S.; Ley, S.V.; Myers, R.M.; Shearman, J.W.; Temple, J.; Unger, J.;Watts, C.A.; Xian, J. A-Ring dihalogenation increases the cellular activity ofcombretastatin-templated tetrazoles.
